HS

Hidradenitis Suppurativa, commonly abbreviated as HS, is a chronic inflammatory skin condition that targets the apocrine sweat glands in dogs. Unlike the eccrine sweat glands found primarily on the paw pads, apocrine glands are distributed across most of the canine body and play a role in scent production rather than thermoregulation. When these glands become inflamed, blocked, or infected, the resulting condition can produce painful nodules, abscesses, and draining sinus tracts in the affected skin.

The disease is characterized by recurring episodes of inflammation that tend to worsen over time if left untreated. Initial presentations may appear similar to simple skin infections or localized abscesses, which can lead to delayed diagnosis. The chronic nature of HS means that affected dogs often experience repeated flare-ups interspersed with periods of relative remission, making ongoing veterinary management essential for maintaining quality of life.

HS in dogs shares some clinical similarities with the human form of the disease, though the underlying pathophysiology differs in several important respects. In canines, the condition most frequently involves the inguinal region, axillae, perineal area, and interdigital spaces where apocrine glands are concentrated. The warm, moist environment of these anatomical regions creates conditions favorable for bacterial colonization of compromised glandular tissue.

While HS is not considered a common condition in the general dog population, it occurs with sufficient frequency that veterinary dermatologists recognize it as a distinct clinical entity. The condition can affect dogs of any age, though it most often presents in young adult to middle-aged animals. Early recognition and intervention are critical for preventing the progressive tissue damage that characterizes advanced stages of the disease.

The exact etiology of Hidradenitis Suppurativa in dogs remains incompletely understood, but current veterinary research points to a multifactorial process involving glandular occlusion, immune dysregulation, and secondary bacterial infection. The primary event is believed to be follicular occlusion or blockage of the apocrine gland duct, which leads to glandular distension, rupture of the gland wall into surrounding tissue, and a subsequent intense inflammatory response.

Genetic predisposition plays a meaningful role in the development of HS. Certain breeds with thicker skin, prominent skin folds, or dense subcutaneous tissue appear to be at elevated risk. Shar-Peis, with their characteristic deep skin folds, are particularly susceptible due to the microenvironment created within those folds. English Bulldogs, Great Danes, and Labrador Retrievers also demonstrate higher incidence rates compared to the general canine population, suggesting heritable factors in glandular anatomy or immune function.

Secondary bacterial infection is a nearly universal complicating factor in HS. Staphylococcus pseudintermedius and other commensal skin bacteria readily colonize the compromised glandular tissue, intensifying the inflammatory response and contributing to abscess formation. In some cases, mixed bacterial populations including anaerobic organisms are identified on culture, reflecting the deep tissue involvement characteristic of advanced lesions.

Environmental and physiological factors also contribute to disease expression. Obesity increases mechanical friction and creates additional skin folds where moisture accumulates, promoting glandular occlusion. Hormonal influences, particularly androgens, may modulate glandular activity and susceptibility to occlusion. Heat and humidity can exacerbate the condition by increasing apocrine gland secretion and promoting bacterial growth in affected areas.

Immune system dysfunction, whether primary or secondary to chronic antigenic stimulation, appears to perpetuate the inflammatory cycle in HS. Dogs with concurrent allergic skin disease or immune-mediated conditions may be at increased risk for developing HS, suggesting that systemic immune dysregulation can lower the threshold for glandular inflammation.

The clinical presentation of HS in dogs typically begins with small, firm nodules in areas where apocrine glands are densely concentrated. These initial lesions may be subtle and easily overlooked during routine examination, particularly in dogs with thick coats or abundant skin folds. Owners often first notice the condition when a nodule becomes painful, enlarges, or begins to drain purulent or serosanguinous fluid.

As the disease progresses, the nodules evolve into larger, deeper abscesses that may coalesce to form interconnected sinus tracts beneath the skin surface. These tracts create channels through which inflammatory exudate drains, often producing a foul-smelling discharge that stains the fur and surrounding skin. The affected areas typically display erythema, edema, warmth, and tenderness to palpation, and the dog may exhibit behavioral changes such as reluctance to walk, sit, or allow handling of the affected regions.

The anatomical distribution of lesions follows the concentration of apocrine glands and areas subject to friction and moisture retention. The inguinal region, axillae, perineum, ventral neck, and interdigital spaces are the most commonly affected sites. In severe cases, lesions may extend to the flanks, ventral abdomen, and medial thighs. The bilateral and often symmetric distribution of lesions can help differentiate HS from localized infections or traumatic wounds.

Chronic HS leads to progressive tissue changes including fibrosis, scarring, and contracture of the affected skin. The repeated cycles of inflammation and healing produce thickened, indurated skin with permanent changes in texture and pigmentation. In advanced cases, the scarring can become so extensive that it restricts normal movement, particularly when the axillary or inguinal regions are heavily involved.

Systemic signs may accompany severe flare-ups, including lethargy, decreased appetite, fever, and regional lymph node enlargement. Dogs experiencing significant pain from active lesions may become irritable, exhibit changes in temperament, or develop self-traumatic behaviors such as excessive licking, chewing, or scratching of the affected areas, which further complicates the clinical picture.

Diagnosing HS in dogs requires a systematic approach that combines clinical examination, laboratory testing, and histopathological evaluation. The initial diagnostic step involves a thorough dermatological examination with careful documentation of lesion distribution, morphology, and chronicity. A detailed clinical history is essential, as the recurrent nature of the condition and its predilection for specific anatomical sites are important diagnostic clues.

Cytological examination of exudate from draining lesions provides rapid preliminary information about the inflammatory process and any bacterial involvement. Impression smears or fine-needle aspirates typically reveal a pyogranulomatous inflammatory pattern with degenerative neutrophils, macrophages, and variable numbers of bacteria. While cytology alone is not diagnostic for HS, it helps guide initial antimicrobial therapy and narrows the differential diagnosis.

Bacterial culture and sensitivity testing should be performed on deep tissue samples rather than surface swabs, as superficial cultures may yield contaminant organisms that do not reflect the true pathogenic flora of deeper lesions. Deep tissue culture is particularly important for guiding long-term antibiotic selection, as many dogs with chronic HS harbor resistant bacterial populations due to prior empirical antibiotic therapy.

Histopathological examination of biopsy specimens is the gold standard for confirming a diagnosis of HS. Characteristic findings include apocrine gland inflammation and destruction, periglandular infiltration with neutrophils and macrophages, follicular occlusion, sinus tract formation, and fibrosis of surrounding tissue. Biopsy samples should be obtained from the margin of active lesions where the characteristic glandular pathology is most likely to be preserved.

Additional diagnostic testing may include complete blood count, serum biochemistry, and thyroid panel to evaluate for systemic disease or concurrent endocrine conditions that may predispose to or exacerbate HS. Imaging modalities such as ultrasonography can be useful for mapping the extent of sinus tracts and identifying deep abscesses that may not be clinically apparent on surface examination.

Treatment of HS in dogs is multimodal and must be tailored to the severity and stage of the disease. Mild cases with limited, superficial lesions may respond to topical therapy combined with systemic antibiotics, while advanced cases with extensive sinus tracts and scarring often require surgical intervention in addition to medical management. The overarching goal of treatment is to reduce inflammation, control bacterial infection, promote healing, and minimize recurrence.

Systemic antibiotic therapy forms the cornerstone of medical management for HS. Antibiotic selection should be guided by culture and sensitivity results whenever possible, with treatment courses typically extending four to eight weeks or longer to adequately address deep-seated infection. Commonly used antibiotics include cephalexin, clindamycin, amoxicillin-clavulanate, and fluoroquinolones, though the specific choice depends on the bacterial species and resistance patterns identified. Premature discontinuation of antibiotics is a common cause of treatment failure and recurrence.

Topical therapy serves as an important adjunct to systemic treatment. Antiseptic washes containing chlorhexidine or benzoyl peroxide can help reduce bacterial colonization of affected skin and promote drainage of superficial lesions. Topical mupirocin or silver sulfadiazine may be applied directly to draining lesions to provide localized antibacterial activity. Regular cleansing of affected areas helps prevent secondary contamination and accelerates healing.

Anti-inflammatory therapy may be incorporated to modulate the excessive immune response that drives tissue destruction in HS. Corticosteroids, while effective at reducing inflammation, must be used judiciously due to their immunosuppressive effects and potential to promote secondary infection. Non-steroidal anti-inflammatory drugs can provide pain relief and modest anti-inflammatory benefit with fewer immunological side effects. In refractory cases, immunomodulatory agents such as cyclosporine have shown promise in controlling the aberrant immune response.

Surgical intervention becomes necessary when medical management fails to control the disease or when extensive sinus tracts and scarring have developed. Surgical options range from incision and drainage of individual abscesses to wide excision of affected tissue with primary closure or healing by second intention. In cases involving extensive regional disease, radical excision with reconstructive surgery may be required to remove all affected tissue and restore functional anatomy.

Surgical management of HS in dogs requires careful preoperative planning to achieve complete excision of diseased tissue while preserving function and minimizing morbidity. The decision to pursue surgery is typically made when conservative medical therapy has failed to control progressive disease, when chronic sinus tracts have formed, or when extensive fibrosis impairs the dog's comfort and mobility.

Preoperative assessment should include thorough mapping of all sinus tracts and affected tissue, which may involve a combination of physical examination, ultrasonography, and contrast sinography. Understanding the full extent of the disease below the skin surface is critical, as incomplete excision is the most common cause of surgical failure and disease recurrence. The surgeon must plan margins that encompass all grossly affected tissue while accounting for the tendency of sinus tracts to extend well beyond their external openings.

The standard surgical approach involves en bloc excision of the affected skin, subcutaneous tissue, and associated sinus tracts with margins of grossly normal tissue. In the inguinal and axillary regions, this may require mobilization of adjacent skin flaps for primary closure. When the defect is too large for primary closure, healing by second intention with appropriate wound management can produce acceptable outcomes, though the healing period is prolonged and requires intensive postoperative care.

Postoperative management is as important as the surgery itself. Closed suction drains are typically placed to prevent seroma formation and remove residual exudate from the surgical site. Continuation of systemic antibiotics through the postoperative period is standard practice, with the duration guided by culture results and clinical response. Elizabethan collars or protective garments are essential to prevent self-trauma to the surgical site during healing.

Outcomes following surgical management vary depending on the extent of disease and completeness of excision. Dogs with localized disease that undergo complete excision have a favorable prognosis, with recurrence rates significantly lower than those treated with medical management alone. However, dogs with widespread, multifocal disease may experience recurrence at new sites even after successful excision of previously affected areas, underscoring the systemic nature of the underlying disease process.

Long-term management of HS in dogs is essential because the condition tends to follow a chronic, relapsing course even with appropriate treatment. A comprehensive management plan should address ongoing disease surveillance, preventive measures, and rapid intervention at the earliest signs of recurrence. Regular veterinary follow-up, typically every three to six months during stable periods, allows for early detection of new or recurrent lesions before they progress to advanced stages.

Weight management is one of the most impactful long-term interventions for dogs with HS. Maintaining an ideal body condition reduces mechanical friction between skin surfaces, decreases the depth and moisture content of skin folds, and may favorably influence the hormonal and inflammatory milieu that contributes to glandular occlusion. A structured diet and exercise program should be developed in collaboration with the veterinary team and tailored to the individual dog's needs and physical limitations.

Skin hygiene protocols should be established as part of the ongoing management regimen. Regular bathing with antiseptic shampoos, particularly focusing on anatomical sites prone to recurrence, can reduce bacterial colonization and prevent glandular occlusion. The frequency of bathing should be balanced against the risk of excessive drying or irritation of the skin, which could paradoxically worsen the condition. Owners should be instructed in the proper technique for cleansing skin folds and inspecting commonly affected areas.

Environmental modifications can help minimize triggers for disease flare-ups. Providing cool, clean bedding reduces heat and moisture accumulation in susceptible areas. Avoiding rough or abrasive surfaces that could cause mechanical irritation to the skin is important, particularly for dogs with inguinal or axillary involvement. Climate considerations may also be relevant, as dogs in hot, humid environments may benefit from increased access to air conditioning and more frequent skin care.

Owner education is a critical component of successful long-term management. Owners must understand the chronic nature of HS, the importance of adherence to prescribed maintenance therapies, and the early signs of disease recurrence that warrant veterinary attention. Providing written instructions for home care, including skin inspection schedules and antiseptic bathing protocols, empowers owners to take an active role in managing their dog's condition between veterinary visits.

Hidradenitis Suppurativa can significantly impact a dog's quality of life through a combination of physical discomfort, restricted mobility, and behavioral changes. The pain associated with active lesions, particularly deep abscesses and inflamed sinus tracts, can be substantial and may not always be obvious to owners unfamiliar with subtle signs of pain in dogs. Assessment of pain using validated canine pain scales should be incorporated into every clinical evaluation.

Mobility impairment is a common consequence of HS, especially when lesions involve the axillary or inguinal regions. Pain and scarring in these areas can restrict normal range of motion, leading to an altered gait, reluctance to exercise, and difficulty with routine activities such as climbing stairs or jumping onto furniture. Over time, the reduction in physical activity can contribute to weight gain, creating a vicious cycle that exacerbates the underlying condition.

Behavioral changes associated with chronic pain and discomfort may include increased irritability, withdrawal from social interaction, changes in sleeping patterns, and decreased appetite. Some dogs develop anxiety-related behaviors in response to repeated painful episodes, particularly if they associate handling or veterinary visits with exacerbation of their discomfort. Recognizing these behavioral shifts as manifestations of the disease rather than primary behavioral problems is important for appropriate management.

The malodorous discharge from draining lesions can affect the human-animal bond, as owners may find it difficult to maintain close physical contact with an affected dog. This can lead to social isolation of the dog within the household and reduced positive interactions that are important for canine emotional wellbeing. Addressing the discharge through appropriate medical management and hygiene protocols can help preserve the owner-pet relationship.

Multimodal pain management strategies are essential for maintaining quality of life in dogs with HS. This may include systemic analgesics, topical anesthetics applied to painful lesions, physical therapy to maintain range of motion, and environmental modifications to reduce pain-provoking activities. The goal is to allow the dog to maintain normal daily activities and social interactions despite the presence of chronic disease.

The prognosis for dogs diagnosed with HS depends on several interrelated factors, including the extent and severity of disease at the time of diagnosis, the dog's response to initial therapy, and the owner's ability to maintain long-term management protocols. Early-stage disease that is identified and treated promptly carries a significantly better prognosis than advanced disease characterized by extensive sinus tract formation and deep tissue fibrosis.

Dogs with localized disease involving a single anatomical site generally have the most favorable outcomes. When lesions are confined to one area, complete surgical excision combined with appropriate perioperative medical management can achieve long-term remission in a substantial proportion of cases. The likelihood of recurrence at the original site following complete excision is relatively low, though new lesions may develop at other anatomically susceptible sites over time.

Multifocal or widespread disease presents a more guarded prognosis. Dogs with lesions at multiple sites often require prolonged or indefinite medical management, as surgical excision of all affected areas may not be feasible. These cases typically follow a waxing and waning course with periods of relative quiescence punctuated by flare-ups that require intensification of therapy. The cumulative tissue damage from repeated inflammatory episodes can progressively compromise skin integrity and function.

Breed-related factors influence the long-term outlook for individual dogs. Breeds with inherent anatomical predispositions, such as the deep skin folds of Shar-Peis, may experience more frequent and severe recurrences compared to breeds without these structural risk factors. In some cases, surgical reduction of skin folds in predisposed breeds can reduce the frequency and severity of flare-ups by eliminating the microenvironment that promotes glandular occlusion.

Advances in veterinary dermatology continue to improve the outlook for dogs with HS. Emerging therapies, including targeted immunomodulatory agents and biologic drugs adapted from human HS treatment protocols, offer promise for better disease control with fewer side effects than traditional approaches. Ongoing research into the pathogenesis of canine HS may identify new therapeutic targets and ultimately lead to more effective prevention and treatment strategies.

While complete prevention of HS may not be possible in genetically predisposed dogs, several strategies can meaningfully reduce the risk of disease onset and minimize the frequency and severity of recurrences in affected animals. A proactive approach to risk reduction should begin with breed-informed awareness and continue through the dog's lifetime with consistent attention to skin health and general wellness.

Breed selection counseling is an important first step in prevention. Prospective dog owners should be informed about the increased risk of dermatological conditions, including HS, in predisposed breeds. Responsible breeders should consider the dermatological history of breeding stock and avoid pairing individuals with a history of chronic skin disease. While genetic testing for HS susceptibility is not currently available in dogs, awareness of family history can guide informed breeding decisions.

Maintaining optimal body condition is one of the most effective preventive measures. Excess body weight increases skin fold depth, promotes friction between opposing skin surfaces, and creates warm, moist microenvironments that predispose to glandular occlusion and bacterial colonization. A balanced diet formulated to support ideal body condition, combined with regular exercise appropriate to the dog's breed and age, can substantially reduce the risk of HS onset and recurrence.

Regular grooming and skin care tailored to the individual dog's coat type and skin characteristics can help prevent the conditions that lead to glandular occlusion. This includes routine cleansing of skin folds, careful drying of moisture-prone areas after bathing or swimming, and regular inspection of commonly affected anatomical sites. Dogs with heavy coats may benefit from judicious trimming around the inguinal and axillary regions to improve air circulation and reduce moisture retention.

Prompt veterinary attention for any skin abnormality is essential for preventing the progression of early HS lesions to advanced disease. Owners should be educated about the early signs of glandular inflammation, including small, firm nodules, localized redness, and mild discharge in the skin folds or groin area. Addressing these early lesions with appropriate topical and systemic therapy can prevent the establishment of chronic sinus tracts and minimize the cumulative tissue damage that makes advanced HS so challenging to manage.